ADAG
Adagene Inc.NASDAQHealthcare$3.99+8.27%ClosedMarket Cap: $150.4M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
4.29
P/S
1578.29
EV/EBITDA
-3.00
DCF Value
$1.64
FCF Yield
-21.0%
Div Yield
0.0%
Margins & Returns
Gross Margin
-1088.5%
Operating Margin
-41197.5%
Net Margin
-37235.6%
ROE
-86.9%
ROA
-57.8%
ROIC
-94.9%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q2 2025 | $0.00 | -Infinity% | $-15.7M | $-13.5M | $-0.36 | — |
| Q4 2024 | $103.2K | -797.5% | $-26.8M | $-24.9M | $-0.71 | — |
| FY 2024 | $103.2K | -797.5% | $-36.0M | $-33.4M | $-0.95 | — |
| Q2 2024 | $0.00 | NaN% | $-9.2M | $-8.5M | $-0.24 | — |
| Q1 2024 | $0.00 | NaN% | $-9.2M | $-8.5M | $-0.24 | — |
| Q4 2023 | $407.9K | -4.3% | $-9.3M | $-7.4M | $-0.21 | — |
| FY 2023 | $18.1M | 100.0% | $-23.7M | $-18.9M | $-0.54 | — |
| Q3 2023 | $407.9K | 100.0% | $-9.3M | $-7.4M | $-0.21 | — |
| Q2 2023 | $8.6M | 0.0% | $-2.5M | $-2.1M | $-0.06 | — |
| Q1 2023 | $8.6M | 100.0% | $-2.5M | $-2.1M | $-0.06 | — |
| Q4 2022 | $2.7M | 0.9% | $-17.9M | $-16.2M | $-0.47 | — |
| FY 2022 | $9.3M | 100.0% | $-83.9M | $-80.0M | $-2.31 | — |